Successful steroid pulse treatment in childhood acquired haemophilia with nephrotic syndrome

Haemophilia

Volumn 11, Issue 3, 2005, Pages 285-289

  Sakai, Michio ^a   Shima, M ^b   Shirahata, A ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Acquired haemophilia; Childhood; Nephrotic syndrome; Recombinant activated FVII; Steroid pulse therapy

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; BLOOD CLOTTING FACTOR 8 INHIBITOR; CYCLOSPORIN; IMMUNOGLOBULIN G1 ANTIBODY; METHYLPREDNISOLONE; PHOSPHOLIPID ANTIBODY; PREDNISONE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; STEROID;

ANTIBODY TITER; ARTICLE; CASE REPORT; DRUG PULSE THERAPY; ECCHYMOSIS; HEMOPHILIA; HEMOSTASIS; HUMAN; HYPOALBUMINEMIA; MALE; MUSCLE BLEEDING; NEPHROTIC SYNDROME; PARTIAL THROMBOPLASTIN TIME; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEINURIA; RECURRENT DISEASE; SIDE EFFECT; STEROID THERAPY; SUBCUTANEOUS TISSUE; TH1 CELL;

AUTOANTIBODIES; CHILD, PRESCHOOL; FACTOR VII; FACTOR VIII; GLUCOCORTICOIDS; HEMOPHILIA A; HUMANS; IMMUNOGLOBULIN G; MALE; METHYLPREDNISOLONE; NEPHROTIC SYNDROME; PULSE THERAPY, DRUG; RECOMBINANT PROTEINS; TREATMENT OUTCOME;

EID: 19444377440     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2005.01093.x     Document Type: Article

References (22)

1. Hay CR, Baglin TP, Collins PW, Hill FG, Keeling DM. The diagnosis and management of factor VIII and IX inhibitors: a guide from the UK Haemophilia Centre Doctors' Organization (UKHCDO). Br J Haematol 2000; 111: 78-90.
2. Green D, Lechner K. A survey of 215 non-hemophilic patients with inhibitors to factor VIII. Thromb Haemost 1981; 45: 200-3.
3. Morrison AE, Ludlam CA. Acquired haemophilia and its management. Br J Haematol 1995; 89: 231-6.
4. Ji L, Yang R, Yang D et al. Prednisone and low-dose activated prothrombin complex concentrates for FVIII inhibitor in nonhaemophilic patients. Haemophilia 1998; 4: 721-4.
5. Hay CRM, Negrier C, Ludlam CA. The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multi-center study. Thromb Haemost 1997; 78: 1463-7.
6. Spero JA, Lewis JH, Hasiba U. Corticosteroid therapy for acquired FVIII:C inhibitors. Br J Haematol 1981; 48: 635-42.
7. Green D, Rademaker AW, Briet E. A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies. Thromb Haemost 1993; 70: 753-7.
8. Schwartz RS, Gabriel DA, Aledort LM, Green D, Kessler CM. A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high-dose intravenous gammaglobulin. Blood 1995; 86:797-804.
9. Sunagawa T, Uezu Y, Kadena K, Tokuyama K, Kinjo F, Saito A. Successful treatment of a non-haemophilic patient with inhibitor to factor VIII by double-filtration plasmapheresis. Br J Haematol 1999; 104: 465-7.
10. Hardisty RM, Macpherson JC. A one-stage factor VIII (antihaemophilic globulin) assay and its use on venous and capillary plasma. Thromb Diath Haemorrh 1962; 7: 215-28.
11. 1689 detected by a novel ELISA. Br J Haematol 1994; 86: 106-11.
12. Kasper CK, Aledort LM, Counts RB et al. A more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh 1975; 34: 869-72.
13. Matsumoto T, Shima M, Fukuda K et al. Immunological characterization of factor VIII autoantibodies in patients with acquired hemophilia A in the presence or absence of underlying disease. Thromb Res 2001; 104: 381-8.
14. Shima M, Tanaka I, Kawai Y, Tsuji H, Nakamura S, Morita T. A survey of acquired inhibitors of blood coagulation in Japan. Jpn J Thromb Hemost 2003; 14: 107-21.
15. Moraca RJ, Ragni MV. Acquired anti-FVIII inhibitors in children. Haemophilia 2002; 8: 28-32.
16. Klein KG, Parkin JD, Madaras F. Studies on an acquired inhibition of factor VIII induced by penicillin allergy. Clin Exp Immnunol 1976; 26: 155-61.
17. Shalhoub RJ. Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet 1974; 2: 556-9.
18. Schulman S, Langevitz P, Livneh A, Mortinowitz U, Seligsohn U, Varon D. Cyclosporine therapy for acquired factor VIII inhibitor in a patient with syatemic lupus erythematosus. Thromb Haemost 1996; 76: 344-6.
19. Collins P, Macartney N, Davies R, Lees S, Giddings J, Majer R. A population based, unselected, consecutive cohort of patients with acquired haemophilia A. Br J Haematol 2004; 124: 86-90.
20. Hu GL, Okita DK, Diethelm-Okita BM, Conti-Fine BM. Recognition of coagulation factor VIII by CD4+ T cells of healthy humans. J Thromb Haemost 2003; 1: 2159-66.
21. Reding MT, Lei S, Lei H, Green D, Gill J, Conti-Fine BM. Distribution of the Th1- and Th2-induced anti-factor VIII IgG subclasses in congenital and acquired hemophilia patients. Thromb Haemost 2002; 88: 568-75.
22. Prescott R, Nakai H, Saenko EL et al. The inhibitor antibody response is more complex in hemophilia A patients than in most nonhemophiliacs with factor VIII autoantibodies. Blood 1997, 89: 3663-71.